Important notification
06.03.2017 To the attention of interested persons The National Agency for Medicines and Medical Devices (NAMMD), member of the European […]
Press release
06.03.2017 To the attention of interested persons The National Agency for Medicines and Medical Devices (NAMMD), member of the European […]
Press release
27.02.2017 To the attention of interested persons Ema press release on SGLT2 inhibitors: information on potential risk of toe amputation […]
Press release
14.02.2017 To the attention of interested persons EMA to review persistence of side effects known to occur with quinolone and […]
Press release
14.02.2017 To the attention of interested persons EMA reviewing safety of Uptravi for pulmonary arterial hypertension download document …
Press release
14.02.2017 To the attention of interested persons EMA press release: PRAC concludes that diabetes medicine canagliflozin may contribute to risk […]
Press release
01.02.2017 To the attention of interested persons EMA press release: Dienogest/ethinylestradiol can be used for acne after certain other treatments […]
Important notification
27.01.2017 To the attention of interested persons Please be advised that, as of 01.02.2017, all original signed documents issued by […]
Important notification
20.01.2017 To the attention of interested persons Please be informed that the NAMMD is not open during 23.01-24.01.2017.
Important notification
18.01.2017 To the attention of interested persons Considering the obligation, in accordance with legislation in force, of declaring sponsoring by […]